Although Alpelisib has shown significant inhibitory effects in clinical practice, the high cost of the original branded drug often discourages patient···【Read More】
Update: 2026-06-12Source: Haiou HealthViews: 119
For patients in urgent need of PIK3CA inhibitors to control their condition, the emergence of the Lao Big Bear Pharmaceutical version of Alpelisib not···【Read More】
Update: 2026-06-12Source: Haiou HealthViews: 115
As the world's first oral inhibitor approved for the treatment of PIK3CA-mutated advanced breast cancer, the generic version of Alpelisib produced···【Read More】
Update: 2026-06-12Source: Haiou HealthViews: 116
When it comes to anti-cytomegalovirus therapy, the Lao Xiong version of Valganciclovir is an unavoidable name. As a prodrug of ganciclovir, it offers ···【Read More】
Update: 2026-06-12Source: Haiou HealthViews: 124
For many patients at risk of cytomegalovirus infection, the Laotian Dabear version of Valganciclovir, with its reliable generic quality and significan···【Read More】
Update: 2026-06-12Source: Haiou HealthViews: 122
Valtrex (Valganciclovir) produced by Lao Bear Pharmaceutical plays a central role in the prevention and treatment of cytomegalovirus infection, provid···【Read More】
Update: 2026-06-12Source: Haiou HealthViews: 122
When the high cost of branded drugs becomes a treatment barrier, the Dacomitinib version manufactured by Laos Big Bear Pharmaceutical builds a bridge ···【Read More】
Update: 2026-06-11Source: Haiou HealthViews: 141
As a second-generation EGFR tyrosine kinase inhibitor, Dacomitinib plays a key role in the treatment of non-small cell lung cancer, and the Laos Dabea···【Read More】
Update: 2026-06-11Source: Haiou HealthViews: 129
Для пациентов с раком легких, испытывающих финансовые трудности, непатентованная версия дакомитиниба, выпущенная компанией Lao Big Bear Pharmaceutical···【Read More】
Update: 2026-06-11Source: Haiou HealthViews: 145
As a potent and highly selective MEK1/2 inhibitor, the Lao Big Bear version of Cobimetinib has demonstrated a clinical response rate and safety profil···【Read More】
Update: 2026-06-11Source: Haiou HealthViews: 123
The Laos Dabear version of Cobimetinib, as the first generic alternative to the original drug "Cobimetinib" in the Southeast Asian region, i···【Read More】
Update: 2026-06-11Source: Haiou HealthViews: 134
With the accessibility of targeted anticancer drugs receiving increasing attention, the generic version of Cobimetinib launched by Lao Bear Pharmaceut···【Read More】
Update: 2026-06-11Source: Haiou HealthViews: 138
Laos Daxiong version of Avatrombopag, as a novel thrombopoietin receptor agonist, provides a convenient and effective oral treatment option for patien···【Read More】
Update: 2026-06-10Source: Haiou HealthViews: 128
The Lao Big Bear version of Avatrombopag is a compliantly manufactured generic drug, providing patients with thrombocytopenia a treatment option that ···【Read More】
Update: 2026-06-09Source: Haiou HealthViews: 110
As a targeted drug focusing on the core pathological link of thrombocytosis, the Lao Big Bear version of Anagrelide not only continues the efficacy me···【Read More】
Update: 2026-06-05Source: Haiou HealthViews: 125
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos